Increased Glypican-3 immunostaining is associated with longer survival outcomes in colorectal carcinoma.

Al-Maghrabi, Jaudah; Al-Mansouri, Zuhoor; Al-Harbi, Abdullah; Assidi, Mourad; Buhmeida, Abdelbaset; Gomaa, Wafaey

Al-Maghrabi, Jaudah; Al-Mansouri, Zuhoor; Al-Harbi, Abdullah; Assidi, Mourad; Buhmeida, Abdelbaset; Gomaa, Wafaey.

Afiliação

Al-Maghrabi J; Department of Pathology, King Abdulaziz University, Jeddah, Saudi Arabia.
Al-Mansouri Z; Department of Pathology, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.
Al-Harbi A; Department of Pathology, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.
Assidi M; Department of Pathology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.
Buhmeida A; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.
Gomaa W; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.

Pol J Pathol ; 73(1): 14-20, 2022.

Article em En | MEDLINE | ID: mdl-35848476

Assuntos

Neoplasias Colorretais; Glipicanas; Biomarcadores Tumorais/metabolismo; Neoplasias Colorretais/patologia; Intervalo Livre de Doença; Glipicanas/metabolismo; Humanos; Imuno-Histoquímica; Prognóstico

Palavras-chave

colorectal carcinoma; immunostaining; survival; glypican-3

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Glipicanas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Pol J Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Arábia Saudita

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google